Bupivacaine Hydrochloride Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Bupivacaine Hydrochloride Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Feb 20, 2018. Reported reason: Other

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-1761-10
Dosage Form
Injection
Presentation
Marcaine, Injection, 0.75% 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25% (NDC 0409-1761-10)
Initial Posting
Feb 20, 2018

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.